T45.691
Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional)
Clinical Classification Guidelines
Inclusion Terms
- Poisoning by other fibrinolysis-affecting drug NOS
Medical Intelligence & Overview
Poisoning by fibrinolysis-affecting drugs refers to an accidental exposure to medications that influence the body's ability to break down blood clots. These drugs are typically used medically for specific clot-related conditions, but accidental overdose or misuse can lead to poisoning. The ICD-10 code T45.691 captures cases where such poisoning occurs unintentionally, emphasizing the importance of careful medication management and awareness.
Causes & Symptoms
Clinical Causes: Accidental overdose of fibrinolysis-affecting medication Misinterpretation of dosage instructions Swallowing medications not intended for oral use -confusion with other drugs leading to incorrect administration Errors during medication preparation or dispensing
Key Symptoms: Unexplained bleeding or hemorrhage Easy bruising Blood in urine or stool Drop in blood pressure Lightheadedness or dizziness Signs of bleeding in other organs, such as the brain or joints
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically made based on medical history, including recent medication exposure, clinical examination, and laboratory tests. Blood tests like coagulation profiles (e.g., PT, aPTT) can reveal abnormal clotting times indicative of fibrinolytic activity. Identifying the specific offending drug through medical history and medication review is essential for accurate diagnosis.
Treatment Protocols: Treatment involves immediate medical intervention aimed at reversing fibrinolysis and controlling bleeding. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T45.691 a billable ICD-10 code?
Yes, T45.691 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.691?
Clinical documentation must specify the nature of Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference